Researchers used protein sequence data analysis and genome editing technology to find that sperm protein SPATA33 plays an important role in sperm motility regulation. Their findings will aid in the development of male contraceptives and the investigation of the cause of male infertility.
from Women's Health News -- ScienceDaily https://ift.tt/3sU1Sh1
Friday, August 27, 2021
Tuesday, August 24, 2021
High cholesterol fuels cancer by fostering resistance to a form of cell death
A research team has identified how breast cancer cells use cholesterol to develop tolerance to stress, making them impervious to death as they migrate from the original tumor site.
from Women's Health News -- ScienceDaily https://ift.tt/3guK4DW
from Women's Health News -- ScienceDaily https://ift.tt/3guK4DW
High cholesterol fuels cancer by fostering resistance to a form of cell death
A research team has identified how breast cancer cells use cholesterol to develop tolerance to stress, making them impervious to death as they migrate from the original tumor site.
from Breast Cancer News -- ScienceDaily https://ift.tt/3guK4DW
from Breast Cancer News -- ScienceDaily https://ift.tt/3guK4DW
High cholesterol fuels cancer by fostering resistance to a form of cell death
A research team has identified how breast cancer cells use cholesterol to develop tolerance to stress, making them impervious to death as they migrate from the original tumor site.
from Women's Health News -- ScienceDaily https://ift.tt/3guK4DW
from Women's Health News -- ScienceDaily https://ift.tt/3guK4DW
Wednesday, August 18, 2021
Prediction models may reduce false-positives in MRI breast cancer screening
Prediction models based on clinical characteristics and imaging findings may help reduce the false-positive rate in women with dense breasts who undergo supplemental breast cancer screening with MRI, according to a new study.
from Breast Cancer News -- ScienceDaily https://ift.tt/2W7hb9R
from Breast Cancer News -- ScienceDaily https://ift.tt/2W7hb9R
Mechanisms of resistance to drug for triple-negative breast cancer identified
Triple-negative breast cancer cells exposed to the antibody-drug conjugate sacituzumab govitecan may develop resistance to this powerful drug through alterations in both the target of the antibody and the target of the toxic payload. The findings illustrate how uncovering such mechanisms will critically inform strategies to overcome resistance to sacituzumab govitecan.
from Breast Cancer News -- ScienceDaily https://ift.tt/3mg7DE7
from Breast Cancer News -- ScienceDaily https://ift.tt/3mg7DE7
Prediction models may reduce false-positives in MRI breast cancer screening
Prediction models based on clinical characteristics and imaging findings may help reduce the false-positive rate in women with dense breasts who undergo supplemental breast cancer screening with MRI, according to a new study.
from Women's Health News -- ScienceDaily https://ift.tt/2W7hb9R
from Women's Health News -- ScienceDaily https://ift.tt/2W7hb9R
Mechanisms of resistance to drug for triple-negative breast cancer identified
Triple-negative breast cancer cells exposed to the antibody-drug conjugate sacituzumab govitecan may develop resistance to this powerful drug through alterations in both the target of the antibody and the target of the toxic payload. The findings illustrate how uncovering such mechanisms will critically inform strategies to overcome resistance to sacituzumab govitecan.
from Women's Health News -- ScienceDaily https://ift.tt/3mg7DE7
from Women's Health News -- ScienceDaily https://ift.tt/3mg7DE7
Prediction models may reduce false-positives in MRI breast cancer screening
Prediction models based on clinical characteristics and imaging findings may help reduce the false-positive rate in women with dense breasts who undergo supplemental breast cancer screening with MRI, according to a new study.
from Women's Health News -- ScienceDaily https://ift.tt/2W7hb9R
from Women's Health News -- ScienceDaily https://ift.tt/2W7hb9R
Mechanisms of resistance to drug for triple-negative breast cancer identified
Triple-negative breast cancer cells exposed to the antibody-drug conjugate sacituzumab govitecan may develop resistance to this powerful drug through alterations in both the target of the antibody and the target of the toxic payload. The findings illustrate how uncovering such mechanisms will critically inform strategies to overcome resistance to sacituzumab govitecan.
from Women's Health News -- ScienceDaily https://ift.tt/3mg7DE7
from Women's Health News -- ScienceDaily https://ift.tt/3mg7DE7
Subscribe to:
Posts (Atom)